The use of mucoadhesive polymers in ocular drug delivery.

In the present update on mucoadhesive ocular dosage forms, the tremendous advances in the biochemistry of mucins, the development of new polymers, the use of drug complexes and other technological advances are discussed. This review focusses on recent literature regarding mucoadhesive liquid (viscous solutions, particulate systems), semi-solid (hydrogel, in situ gelling system) and solid dosage forms, with special attention to in vivo studies. Gel-forming minitablets and inserts made of thiomers show an interesting potential for future applications in the treatment of ocular diseases.

[1]  V. Londhe,et al.  Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. , 1999, International journal of pharmaceutics.

[2]  A. Albertsson,et al.  Preparation and characterisation of poly(adipic anhydride) microspheres for ocular drug delivery , 1996 .

[3]  C. Lehr,et al.  Lectin-mediated drug delivery: the second generation of bioadhesives. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[4]  B. Munoz,et al.  Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. , 1997, Ophthalmology.

[5]  N A Peppas,et al.  Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[6]  L. Balant,et al.  Ocular Availability of Gentamicin in Small Animals After Topical Administration of a Conventional Eye Drop Solution and a Novel Long Acting Bioadhesive Ophthalmic Drug Insert , 1995, Pharmaceutical Research.

[7]  A. Rozier,et al.  Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol , 1992 .

[8]  Andreas Zimmer,et al.  Microspheres and nanoparticles used in ocular delivery systems , 1995 .

[9]  G. Novack,et al.  Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[10]  V. H. Lee,et al.  Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. , 1988, Experimental eye research.

[11]  L. Salminen Review: systemic absorption of topically applied ocular drugs in humans. , 1990, Journal of ocular pharmacology.

[12]  D. Monti,et al.  Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine , 1991 .

[13]  A. Bernkop‐Schnürch,et al.  Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  P. Russo,et al.  Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery , 2002 .

[15]  R M Hill,et al.  The thickness of the human precorneal tear film: evidence from reflection spectra. , 2000, Investigative ophthalmology & visual science.

[16]  S. Garg,et al.  Bioadhesive microspheres as a controlled drug delivery system. , 2003, International journal of pharmaceutics.

[17]  O. Camber,et al.  Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. , 1989, Current eye research.

[18]  A. Bernkop‐Schnürch,et al.  Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  R. Dana,et al.  Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. , 2002, Investigative ophthalmology & visual science.

[20]  P. Versura,et al.  Scanning electron microscopy of normal human corneal epithelium obtained by scraping‐off in vivo , 1985, Acta ophthalmologica.

[21]  S. Kawakami,et al.  One-side-coated insert as a unique ophthalmic drug delivery system. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[22]  A. Joshi,et al.  A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. , 2002, Investigative ophthalmology & visual science.

[23]  A. Ludwig,et al.  Evaluation of polysaccharides intended for ophthalmic use in ocular dosage forms. , 1995, Farmaco.

[24]  R. Farris,et al.  Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. , 1988, Archives of ophthalmology.

[25]  P. Ding,et al.  Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[26]  S. Tseng,et al.  Paracellular permeability of corneal and conjunctival epithelia. , 1989, Investigative ophthalmology & visual science.

[27]  P. Couvreur,et al.  Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides , 1998, Pharmaceutical Research.

[28]  V. Dodane,et al.  Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.

[29]  D. Monti,et al.  Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. , 1994, Journal of ocular pharmacology.

[30]  H. Hägerström,et al.  Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  M. B. Shields,et al.  A dose-response study of piloplex for duration of action. , 1985, American journal of ophthalmology.

[32]  O. Lorenzetti,et al.  Ocular bioavailability of ciprofloxacin in sustained release formulations. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[33]  M. Wirth,et al.  Lectin-mediated drug delivery: fundamentals and perspectives , 2003 .

[34]  Clive G. Wilson,et al.  Ocular contact time of a carbomer gel (GelTears) in humans , 1998, The British journal of ophthalmology.

[35]  Claus-Michael Lehr,et al.  Bioadhesive Drug Delivery Systems : Fundamentals, Novel Approaches, and Development , 1999 .

[36]  C. Allaire,et al.  Ocular hypotensive efficacy and safety of once daily carteolol alginate , 2001, British Journal of Ophthalmology.

[37]  S. P. Srinivas,et al.  Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. , 1992, Journal of pharmaceutical sciences.

[38]  A. Solomon,et al.  The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[39]  P. Sado,et al.  Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. , 1997, Journal of microencapsulation.

[40]  R. Pignatello,et al.  Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. , 2002, Journal of pharmaceutical sciences.

[41]  M. Alonso,et al.  Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles: stabilization approaches. , 1997, Biomaterials.

[42]  O. El-Gazayerly,et al.  Preparation and evaluation of acetazolamide liposomes as an ocular delivery system , 1997 .

[43]  S Tsukahara,et al.  Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation. , 1997, Investigative ophthalmology & visual science.

[44]  S. Burgalassi,et al.  Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[45]  G. Smistad,et al.  Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .

[46]  A. Bernkop‐Schnürch,et al.  Polymers with Thiol Groups: A New Generation of Mucoadhesive Polymers? , 1999, Pharmaceutical Research.

[47]  K. Carraway,et al.  Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. , 2000, Investigative ophthalmology & visual science.

[48]  L. Wilson,et al.  Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy. , 1975, Archives of ophthalmology.

[49]  R. Gurny,et al.  Biomaterials in ophthalmic drug delivery , 1996 .

[50]  D. Craig,et al.  An investigation into the rheological, dielectric and mucoadhesive properties of poly(acrylic acid) gel systems , 1995 .

[51]  R. Gurny,et al.  Bioerodible polymers for ocular drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[52]  M. Fresta,et al.  Characterization and In‐vivo Ocular Absorption of Liposome‐encapsulated Acyclovir , 1999, The Journal of pharmacy and pharmacology.

[53]  S. Yalkowsky,et al.  Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. , 1999, International journal of pharmaceutics.

[54]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[55]  S. Mortazavi,et al.  Factors Influencing Gel‐strengthening at the Mucoadhesive‐mucus Interface , 1994, The Journal of pharmacy and pharmacology.

[56]  N. J. Van Haeringen,et al.  Clinical biochemistry of tears , 1981 .

[57]  A. Ludwig,et al.  The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. , 2002, Journal of pharmaceutical sciences.

[58]  H. Taylor,et al.  The epidemiology of dry eye in Melbourne, Australia , 1998 .

[59]  K. Tsubota,et al.  Sodium hyaluronate eyedrops in the treatment of dry eyes. , 1995, The British journal of ophthalmology.

[60]  John W. Shell Ophthalmic drug delivery systems , 1984 .

[61]  J. Kreuter,et al.  Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles , 1994 .

[62]  A. Urtti,et al.  Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies , 1992 .

[63]  M. Berry,et al.  Commensal ocular bacteria degrade mucins , 2002, The British journal of ophthalmology.

[64]  Robert Gurny,et al.  Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine , 1993 .

[65]  Y. Zambito,et al.  A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide). , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[66]  H. Sasaki,et al.  Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.

[67]  R. Gurny,et al.  Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. , 1997, Pharmaceutica acta Helvetiae.

[68]  A. Bernkop‐Schnürch,et al.  In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. , 2000, Journal of pharmaceutical sciences.

[69]  D. Woodward,et al.  Studies on the ocular pharmacology of prostaglandin D2. , 1990, Investigative ophthalmology & visual science.

[70]  A. Bernkop‐Schnürch,et al.  Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[71]  R. Gurny,et al.  Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation , 1995 .

[72]  I. Gipson,et al.  MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. , 2003, Investigative ophthalmology & visual science.

[73]  A S Hoffman,et al.  An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[74]  S. Burgalassi,et al.  Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes , 1999, Ophthalmic Research.

[75]  J. Liaw,et al.  In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles , 2001, Gene Therapy.

[76]  R. Gurny,et al.  Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[77]  J. Jumblatt,et al.  MUC7 Expression in the Human Lacrimal Gland and Conjunctiva , 2003, Cornea.

[78]  M. Ohji,et al.  Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis. , 1993, American journal of ophthalmology.

[79]  M. F. Saettone,et al.  The validity of rabbits for investigations on ophthalmic vehicles: a comparison of four different vehicles containing tropicamide in humans and rabbits. , 1982, Pharmaceutica acta Helvetiae.

[80]  R. Gurny,et al.  Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[81]  P. Furrer,et al.  Étude comparative de la tolérance oculaire de 3 spécialités à base de timolol : influence du conservateur sur la tolérance oculaire , 2001 .

[82]  A. Bron,et al.  Physical properties of stimulated and unstimulated tears. , 1999, Experimental eye research.

[83]  L. P. Aristoteli,et al.  Isolation of conjunctival mucin and differential interaction with Pseudomonas aeruginosa strains of varied pathogenic potential. , 2003, Experimental Eye Research.

[84]  Hormone replacement therapy and dry eye syndrome. , 2001 .

[85]  L. Nielsen,et al.  Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate , 1998 .

[86]  A. Sharma,et al.  Mechanism of Tear Film Rupture and Formation of Dry Spots on Cornea , 1985 .

[87]  I. Gipson,et al.  The role of calcium in mucin packaging within goblet cells. , 2003, Experimental eye research.

[88]  T. Fujihara,et al.  P2Y(2) receptor elicits PAS-positive glycoprotein secretion from rabbit conjunctival goblet cells in vivo. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[89]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[90]  J. Robinson,et al.  Bioadhesive and phase-change polymers for ocular drug delivery , 1995 .

[91]  R. Huupponen,et al.  Macromolecular ionic complexes of cyclopentolate for topical ocular administration. Preparation and preliminary evaluation in albino rabbits , 1992 .

[92]  P. Dilly On the nature and the role of the subsurface vesicles in the outer epithelial cells of the conjunctiva. , 1985, The British journal of ophthalmology.

[93]  J. Tiffany,et al.  Tears in health and disease , 2003, Eye.

[94]  S. H. Leung,et al.  The contribution of anionic polymer structural features to mucoadhesion , 1987 .

[95]  J. Blanchard,et al.  Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model. , 1998, Journal of pharmaceutical sciences.

[96]  A. Mitra,et al.  Mucoadhesive polymers in ocular drug delivery , 1993 .

[97]  G. Spedalieri,et al.  Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. , 2002, Biomaterials.

[98]  K. Kashiwagi,et al.  Comparison of Efficacy and Tolerability between Two Gel-Forming Timolol Maleate Ophthalmic Solutions in Patients with Glaucoma or Ocular Hypertension , 2003, Ophthalmologica.

[99]  A. Filippelli,et al.  Effects of Timolol and of Timolol with Tamarind Seed Polysaccharide on Intraocular Pressure in Rabbits , 1999 .

[100]  Y. Kawashima,et al.  Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. , 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[101]  K. Tsubota Tear dynamics and dry eye , 1998, Progress in Retinal and Eye Research.

[102]  P. Amin,et al.  Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[103]  A. Corfield,et al.  Secreted human conjunctival mucus contains MUC5AC glycoforms. , 1999, Glycobiology.

[104]  K. Tsubota,et al.  Important concepts for treating ocular surface and tear disorders. , 1997, American journal of ophthalmology.

[105]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[106]  D. Meisner,et al.  Liposome ocular delivery systems , 1995 .

[107]  Robert Gurny,et al.  PATENT LITERATURE REVIEW OF OPHTHALMIC INSERTS , 1995 .

[108]  M Paulsson,et al.  Controlled drug release from gels using surfactant aggregates: I. Effect of lipophilic interactions for a series of uncharged substances. , 2001, Journal of pharmaceutical sciences.

[109]  T. Laurent Biochemistry of hyaluronan. , 1987, Acta oto-laryngologica. Supplementum.

[110]  D. Korb,et al.  Histochemical analysis of secretory vesicles in nongoblet conjunctival epithelial cells , 1985, Acta ophthalmologica.

[111]  J. Robinson,et al.  Ocular delivery of progesterone using a bioadhesive polymer , 1985 .

[112]  M. F. Saettone,et al.  Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man , 1982, The Journal of pharmacy and pharmacology.

[113]  F. Paulsen,et al.  Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. , 2002, Investigative ophthalmology & visual science.

[114]  C. Sébastian,et al.  A new long acting ophthalmic formulation of carteolol containing alginic acid. , 2000, International journal of pharmaceutics.

[115]  I. Gipson,et al.  Characteristics of a glycoprotein in the ocular surface glycocalyx. , 1992, Investigative ophthalmology & visual science.

[116]  Jeong-Sook Park,et al.  rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery , 2002 .

[117]  J. Remon,et al.  Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[118]  E. Lobel,et al.  A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye , 1997 .

[119]  Giovanni Puglisi,et al.  Enhanced Ocular Anti-Inflammatory Activity of Ibuprofen Carried by an Eudragit RS100® Nanoparticle Suspension , 2002, Ophthalmic Research.

[120]  Yang Li,et al.  Characterization of Human Ocular Mucin Secretion Mediated by 15(S)-HETE , 2002, Cornea.

[121]  L. Salminen,et al.  Ocular inserts for topical delivery , 1995 .

[122]  R. Craster,et al.  Analysis of tear film rupture: effect of non-Newtonian rheology. , 2003, Journal of colloid and interface science.

[123]  Ashutosh Sharma,et al.  The role of lipid abnormalities, aqueous and mucus deficiencies in the tear film breakup, and implications for tear substitutes and contact lens tolerance , 1986 .

[124]  J. Jumblatt,et al.  MUC5AC mucin is a component of the human precorneal tear film. , 1999, Investigative ophthalmology & visual science.

[125]  S. Burgalassi,et al.  Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). , 2002, International journal of pharmaceutics.

[126]  J. Remon,et al.  Evaluation of a mucoadhesive tablet for ocular use. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[127]  R. Cavalli,et al.  Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. , 2002, International journal of pharmaceutics.

[128]  F. Campbell,et al.  Study of human precorneal tear film thickness and structure using laser interferometry. , 1992, Investigative ophthalmology & visual science.

[129]  S. Rossi,et al.  Characterization of chitosan hydrochloride--mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[130]  D. Attwood,et al.  In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. , 2001, International journal of pharmaceutics.

[131]  M. Boehnke,et al.  Influences of methylcellulose on corneal epithelial wound healing. , 1999, Journal of Ocular Pharmacology and Therapeutics.

[132]  G. Cavallaro,et al.  Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. , 2001, Journal of pharmaceutical sciences.

[133]  M. Miles,et al.  Atomic force microscopy of the submolecular architecture of hydrated ocular mucins. , 1999, Biophysical journal.

[134]  Lisbeth Illum,et al.  Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2) , 1994, Pharmaceutical Research.

[135]  G. Banchelli,et al.  A New Viscosity Enhancer for Ophthalmic Preparations Devoid of Toxicity for Human Conjunctival Cells , 2000 .

[136]  P. Sado,et al.  New Ophthalmic Drug Delivery Systems , 1995 .

[137]  J. Romanet,et al.  [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. , 2003, Journal francais d'ophtalmologie.

[138]  N. Loya,et al.  The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study. , 1988, Investigative ophthalmology & visual science.

[139]  L. Silver,et al.  Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. , 2000, American journal of ophthalmology.

[140]  S. Leucuţa,et al.  The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine , 1989 .

[141]  C. Koller,et al.  Propriétés et intérêt pharmaceutique des gels thermoréversibles à base de poloxamers et poloxamines , 1987 .

[142]  K. Edsman,et al.  Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers. , 2002, Journal of colloid and interface science.

[143]  M. Calonge The treatment of dry eye. , 2001, Survey of ophthalmology.

[144]  M. F. Saettone,et al.  Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans , 1988 .

[145]  I. Gipson,et al.  Mucin gene expression is not regulated by estrogen and/or progesterone in the ocular surface epithelia of mice. , 2003, Experimental eye research.

[146]  C. Dawson,et al.  Demonstration of the mucous layer of the tear film by electron microscopy. , 1985, Investigative ophthalmology & visual science.

[147]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[148]  E. Rosenlund The intraocular pressure lowering effect of timolol in gel-forming solution. , 2009, Acta ophthalmologica Scandinavica.

[149]  A. Rozier,et al.  Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol , 1989 .

[150]  S. Mortazavi,et al.  An investigation into the role of water movement and mucus gel dehydration in mucoadhesion , 1993 .

[151]  N. Peppas,et al.  Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. , 1997, Journal of biomaterials science. Polymer edition.

[152]  J. C. Robinson Ocular anatomy and physiology relevant to ocular drug delivery , 1993 .

[153]  C. Camras,et al.  Efficacy and Adverse Effects of Medications Used in the Treatment of Glaucoma , 1999, Drugs & aging.

[154]  C. Baudouin,et al.  Retentissement conjonctival des conservateurs : étude comparative de collyres bêta-bloquants conservés et non conservés chez des patients glaucomateux , 2003 .

[155]  Hong-Ru Lin,et al.  Carbopol/pluronic phase change solutions for ophthalmic drug delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[156]  J. Friend,et al.  Goblet cell density in ocular surface disease. A better indicator than tear mucin. , 1983, Archives of ophthalmology.

[157]  L. Balant,et al.  Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[158]  M D Donovan,et al.  Drug transfer through mucus. , 2001, Advanced drug delivery reviews.

[159]  G. Banchelli,et al.  Effect of Xyfoglucan (Tamarind Seed Polysaccharide) on Conjunctival Cell Adhesion to Laminin and on Corneal Epithelium Wound Healing , 2000, European journal of ophthalmology.

[160]  C. Chiang,et al.  Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[161]  C. Bucolo,et al.  Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation , 1998, Ophthalmic Research.

[162]  Robert Gurny,et al.  Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. , 2000, International journal of pharmaceutics.

[163]  I. Gipson,et al.  Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. , 2000, Investigative ophthalmology & visual science.

[164]  C. Baudouin,et al.  Évaluation de la cytotoxicité de trois substituts lacrymaux utilisés dans le traitement des syndromes secs , 2000 .

[165]  M. Alonso,et al.  Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. , 2001, International journal of pharmaceutics.

[166]  S. Burgalassi,et al.  Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. , 2001, International journal of pharmaceutics.

[167]  K. Himmelstein,et al.  Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. , 1995, Journal of pharmaceutical sciences.

[168]  I. Kellaway,et al.  Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye , 1995 .

[169]  P. Perugini,et al.  Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir , 1997, The Journal of pharmacy and pharmacology.

[170]  J. Kreuter,et al.  Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers , 1995 .

[171]  Clive G. Wilson,et al.  Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .

[172]  A. Bernkop‐Schnürch,et al.  Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. , 2003, Journal of pharmaceutical sciences.

[173]  K. Swan USE OF METHYL CELLULOSE IN OPHTHALMOLOGY , 1945 .

[174]  S. Engström,et al.  In vitro release of timolol maleate from an in situ gelling polymer system , 1993 .

[175]  W. Jagla,et al.  Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells. , 1999, Investigative ophthalmology & visual science.

[176]  C. Radke,et al.  Deposition and Thinning of the Human Tear Film , 1996, Journal of colloid and interface science.

[177]  M. F. Saettone,et al.  Polymer effects on ocular bioavailability: the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbits , 1984 .

[178]  R. Herrero-Vanrell,et al.  Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[179]  A. Corfield,et al.  Membrane-associated mucins in normal human conjunctiva. , 2000, Investigative ophthalmology & visual science.

[180]  I. Kaur,et al.  Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery , 2002, Drug development and industrial pharmacy.

[181]  M. Alonso,et al.  The potential of chitosan in ocular drug delivery , 2003, The Journal of pharmacy and pharmacology.

[182]  J. Robinson,et al.  Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. , 1976, Journal of pharmaceutical sciences.

[183]  W. Osborne,et al.  Mucous granule exocytosis and CFTR expression in gallbladder epithelium. , 2000, Glycobiology.

[184]  I. Kellaway,et al.  Precorneal Clearance of Mucoadhesive Microspheres from the Rabbit Eye , 1995, The Journal of pharmacy and pharmacology.

[185]  J. Robinson,et al.  Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes , 1989 .

[186]  P. Lama Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment. , 2002, American journal of ophthalmology.

[187]  Robert Gurny,et al.  Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. , 1999, International journal of pharmaceutics.

[188]  A. Joshi Microparticulates for ophthalmic drug delivery. , 1994, Journal of ocular pharmacology.

[189]  V. H. Lee,et al.  Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. , 1994, Investigative ophthalmology & visual science.

[190]  A. Rozier,et al.  Functionality testing of gellan gum, a polymeric excipient material for ophthalmic dosage forms , 1997 .

[191]  A. Zimmer,et al.  Studies on the transport pathway of PBCA nanoparticles in ocular tissues. , 1991, Journal of microencapsulation.

[192]  D. K. Majumdar,et al.  Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. , 2000, International journal of pharmaceutics.

[193]  A. Mitra,et al.  Ophthalmic Drug Delivery Systems , 2003 .

[194]  N. Yüksel,et al.  The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. , 2009, Acta ophthalmologica Scandinavica.

[195]  A. Bernkop‐Schnürch,et al.  Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. , 2001, Biomaterials.

[196]  G. Snibson,et al.  Ocular Surface Residence Times of Artificial Tear Solutions , 1992, Cornea.

[197]  I. Gipson,et al.  Alteration of mucin in human conjunctival epithelia in dry eye. , 1998, Investigative ophthalmology & visual science.

[198]  P. Couvreur,et al.  Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms. , 1998, Journal of drug targeting.

[199]  I. Gipson,et al.  Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. , 2001, Investigative ophthalmology & visual science.

[200]  T. Inatomi,et al.  Expression of secretory mucin genes by human conjunctival epithelia. , 1996, Investigative ophthalmology & visual science.

[201]  N. Fullwood,et al.  Tight junction-related protein expression and distribution in human corneal epithelium. , 2003, Experimental eye research.

[202]  D. Krohn,et al.  Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux. , 1982, Investigative ophthalmology & visual science.

[203]  P. Chetoni,et al.  Ocular mini-tablets for controlled release of timolol: evaluation in rabbits. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[204]  A. Bernkop‐Schnürch,et al.  The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers , 2002, Pharmaceutical Research.

[205]  A. Hoffman,et al.  Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[206]  A. Ludwig,et al.  A comparative rheological study on carbopol viscous solutions and, the evaluation of their suitability as the ophthalmic vehicles and artificial tears. , 1992, Pharmaceutica acta Helvetiae.

[207]  J. Siepmann,et al.  PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[208]  A Shedden,et al.  Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study. , 2001, Clinical therapeutics.

[209]  J. Jumblatt,et al.  Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. , 1998, Experimental eye research.

[210]  M. Oechsner,et al.  Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[211]  U Conte,et al.  Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[212]  J. Smart,et al.  A rheological assessment of the nature of interactions between mucoadhesive polymers and a homogenised mucus gel. , 1998, Biomaterials.

[213]  F. Holly,et al.  Formation and rupture of the tear film. , 1973, Experimental eye research.

[214]  S. Kawakami,et al.  Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[215]  A. Bernkop‐Schnürch,et al.  Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[216]  M. Ooteghem Factors Influencing the Retention of Ophthalmic Solutions on the Eye Surface , 1987 .

[217]  G. Milazzo,et al.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye , 2002, The British journal of ophthalmology.

[218]  J. Robinson,et al.  Ocular evaluation of methylcellulose vehicle in albino rabbits. , 1974, Journal of pharmaceutical sciences.

[219]  J D Smart,et al.  A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[220]  J. Carlfors,et al.  Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[221]  I. Kellaway,et al.  An investigation of the interfacial interaction between poly(acrylic acid) and glycoprotein , 1998 .

[222]  I. Gipson,et al.  Epithelial mucins of the ocular surface: structure, biosynthesis and function. , 2001, Experimental eye research.

[223]  K. Langer,et al.  Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part III: Evaluation as drug delivery system for ophthalmic applications , 1997 .

[224]  D. Monti,et al.  Muco-Adhesive Liquid Ophthalmic Vehicles - Evaluation of Macromolecular Ionic Complexes of Pilocarpine , 1989 .

[225]  D. Worthen,et al.  An evaluation of the pilocarpine Ocusert. , 1974, Investigative ophthalmology.

[226]  A. El-Kamel In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. , 2002, International journal of pharmaceutics.

[227]  V. H. Lee,et al.  Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability , 2003, Pharmaceutical Research.

[228]  J. Blanchard,et al.  Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. , 2000, Drug delivery.

[229]  J. Carlfors,et al.  Rheological evaluation of Gelrite in situ gels for ophthalmic use. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[230]  A. Bernkop‐Schnürch,et al.  Evidence for the interpenetration of mucoadhesive polymers into the mucous gel layer , 2003 .

[231]  J. Gallo,et al.  A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength , 1990, Pharmaceutical Research.

[232]  R. Prescott,et al.  Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome , 1999, The British journal of ophthalmology.

[233]  S. Rossi,et al.  Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. , 1997, Farmaco.

[234]  J P Gilbard,et al.  Human Tear Film Electrolyte Concentrations in Health and Dry-Eye Disease , 1994, International ophthalmology clinics.

[235]  H. Struck,et al.  Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[236]  Naseem A. Charoo,et al.  Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo Studies , 2003, Drug development and industrial pharmacy.

[237]  R. Gurny,et al.  Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[238]  Shulin Ding RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[239]  H. Kaş Chitosan: properties, preparations and application to microparticulate systems. , 1997, Journal of microencapsulation.

[240]  P. Giunchedi,et al.  Albumin Microspheres for Ocular Delivery of Piroxicam , 2000 .

[241]  R. Gurny,et al.  Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels , 1995 .

[242]  Deshpande,et al.  Ocular drug delivery in veterinary medicine. , 1997, Advanced drug delivery reviews.

[243]  F. Paulsen,et al.  The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. , 2003, Investigative ophthalmology & visual science.

[244]  P. Chetoni,et al.  Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[245]  R. Gorla,et al.  Nonlinear theory of tear film rupture. , 2000, Journal of Biomechanical Engineering.

[246]  J. Tiffany,et al.  Components responsible for the surface tension of human tears. , 1999, Current eye research.

[247]  Susan C. Miller,et al.  Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits , 1982 .

[248]  J. Robinson,et al.  Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.

[249]  D. Rogers,et al.  Lectins in ocular drug delivery: An investigation of lectin binding sites on the corneal and conjunctival surfaces , 1996 .

[250]  S. Burgalassi,et al.  Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide). , 2001, International journal of pharmaceutics.

[251]  Ruxandra Gref,et al.  The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[252]  Robert Gurny,et al.  Design and evaluation of controlled release systems for the eye , 1987 .

[253]  A. Topalkara,et al.  Adverse effects of topical antiglaucoma drugs on the ocular surface , 2000, Clinical & experimental ophthalmology.

[254]  R. Hodges,et al.  Presence of nerves and their receptors in mouse and human conjunctival goblet cells. , 2001, Investigative ophthalmology & visual science.

[255]  S. Burgalassi,et al.  Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[256]  A. Bernkop‐Schnürch,et al.  Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[257]  S. Dinslage,et al.  A comparative bioavailability study of three conventional eye drops versus a single lyophilisate , 2003, The British journal of ophthalmology.

[258]  Y. Tsai,et al.  The Preparation of Norfloxacin‐loaded Liposomes and their In‐vitro Evaluation in Pig's Eye , 1996, The Journal of pharmacy and pharmacology.

[259]  P Buri,et al.  Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.

[260]  A. Ludwig,et al.  Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[261]  H. Taylor,et al.  Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. , 1997, Ophthalmology.

[262]  A. Bernkop‐Schnürch,et al.  In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits. , 2002, Journal of pharmaceutical sciences.

[263]  J. Pintor,et al.  Nucleotides and dinucleotides in ocular physiology: New possibilities of nucleotides as therapeutic agents in the eye , 2003 .

[264]  R. Gurny,et al.  Concept and development of ophthalmic pseudo-latexes triggered by pH , 1991 .

[265]  P. Eustace,et al.  Polyacrylic Acid Gel in Patients with Dry Eyes: A Randomised Comparison with Polyvinyl Alcohol , 1998, European journal of ophthalmology.

[266]  H Lennernäs,et al.  Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[267]  T. Inatomi,et al.  Mucin genes expressed by the ocular surface Epithelium , 1997, Progress in Retinal and Eye Research.

[268]  J. Kreuter Particulates (Nanoparticles and Microparticles) , 1993 .

[269]  J. Greaves,et al.  Polymers and the precorneal tear film , 1992 .

[270]  E. Topp,et al.  Gellan-based systems for ophthalmic sustained delivery of methylprednisolone , 1993 .

[271]  H. Junginger,et al.  Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. , 2001, Journal of pharmaceutical sciences.

[272]  A. Tomlinson,et al.  Effect of oral contraceptives on tear physiology , 2001, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[273]  J. Hardy,et al.  A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man , 1986, The Journal of pharmacy and pharmacology.

[274]  P. Couvreur,et al.  Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel , 1998 .

[275]  A. Ludwig,et al.  Influence of viscolysers on the residence of ophthalmic solutions evaluated by slit lamp fluorophotometry , 1992 .

[276]  S. Klyce,et al.  Determination of tear volume and tear flow. , 1966, Investigative ophthalmology.

[277]  L. Carney,et al.  Relationship between goblet cell density and tear function tests , 2003, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[278]  J. Hadgraft,et al.  Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.

[279]  C. Cho,et al.  Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. , 2003, International journal of pharmaceutics.

[280]  Robert Gurny,et al.  Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. , 2003, International journal of pharmaceutics.

[281]  D. Meller,et al.  Oxidative reactions in the tear fluid of patients suffering from dry eyes , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.

[282]  M. Alonso,et al.  Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .

[283]  T. Inatomi,et al.  Human corneal and conjunctival epithelia express MUC1 mucin. , 1995, Investigative ophthalmology & visual science.

[284]  W. C. Stewart,et al.  Efficacy and Safety of Timolol Solution Once Daily versus Timolol Gel in Treating Elevated Intraocular Pressure , 1998, Journal of glaucoma.

[285]  B. Yerxa Therapeutic use of nucleotides in respiratory and ophthalmic diseases , 2001 .

[286]  S. Hsu,et al.  Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. , 2002, Biomaterials.

[287]  C. Baudouin,et al.  Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. , 2002, Investigative ophthalmology & visual science.

[288]  J. Murube,et al.  Origin and Types of Emotional Tearing , 1999, European journal of ophthalmology.

[289]  Y. Ogura,et al.  Biodegradable Polymers for Ocular Drug Delivery , 2001, Ophthalmologica.

[290]  S. Keipert,et al.  Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use. , 2000, Die Pharmazie.

[291]  L. P. Aristoteli,et al.  Adhesion of Pseudomonas aeruginosa ocular isolates to mucin , 2001, Clinical & experimental ophthalmology.

[292]  H. Brewitt Tränenersatzmittel - Experimentelle und klinische Beobachtungen , 1988 .

[293]  A. Ludwig,et al.  Evaluation of sodium hyaluronate as viscous vehicle for eye drops. , 1989, Journal de pharmacie de Belgique.

[294]  Zhenghe Xu,et al.  Physical characterization of a chitosan-based hydrogel delivery system. , 2002, Journal of pharmaceutical sciences.

[295]  R. Gurny,et al.  Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[296]  E. Rask-Pedersen,et al.  Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study. , 2009, Acta ophthalmologica Scandinavica.

[297]  M. F. Saettone,et al.  Polymer effects on ocular bioavailability. II. The influence of benzalkonium chloride on the mydriatic response of tropicamide in different polymeric vehicles , 1985 .

[298]  A. Bernkop‐Schnürch,et al.  Synthesis and characterisation of mucoadhesive thiolated polymers. , 2000, International journal of pharmaceutics.

[299]  I. Gipson,et al.  C57BL/6 mice lacking Muc1 show no ocular surface phenotype. , 2000, Investigative Ophthalmology and Visual Science.

[300]  I. Kellaway,et al.  Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system , 1992 .

[301]  C. Baudouin Side effects of antiglaucomatous drugs on the ocular surface. , 1996, Current opinion in ophthalmology.

[302]  K. Langer,et al.  Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release , 1997 .

[303]  J. Carlfors,et al.  Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use , 1996 .

[304]  H E Kaufman,et al.  The instilled fluid dynamics and surface chemistry of polymers in the preocular tear film. , 1975, Investigative ophthalmology.

[305]  G. Forstner Signal transduction, packaging and secretion of mucins. , 1995, Annual review of physiology.

[306]  A. Bernkop‐Schnürch,et al.  Development of controlled drug release systems based on thiolated polymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[307]  K. Tsubota,et al.  Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sjogren's Syndrome , 1996, Cornea.

[308]  S. Tsukahara,et al.  Histochemical study on rat tear film and ocular surface epithelial cells , 1998 .

[309]  W. Mathers,et al.  Model for Ocular Tear Film Function , 1996, Cornea.

[310]  A. Bernkop‐Schnürch,et al.  Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[311]  J. Diamond,et al.  Systemic Adverse Effects of Topical Ophthalmic Agents , 1997, Drugs & aging.